Please use this identifier to cite or link to this item:
Title: Interleukin-10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands
Authors: Rosado, S.
Rua-Figueroa, I.
Vargas, J. A.
Garcia-Laorden, M. I.
Losada-Fernandez, I.
Martin-Donaire, T.
Perez-Chacon, G.
Rodriguez-Gallego, C. 
Naranjo-Hernandez, A. 
Ojeda-Bruno, S.
Citores, M. J.
Perez-Aciego, P.
UNESCO Clasification: 32 Ciencias médicas
3205 Medicina interna
Keywords: Lupus erythematosus
Issue Date: 2008
Journal: International Journal of Immunogenetics 
Abstract: The purpose of this study was to examine whether several allelic variants in the polymorphic interleukin (IL)-10 promoter region were related with an increased risk of developing systemic lupus erythematosus (SLE) in Spanish patients from Canary Islands. Microsatellites (MS) at positions -4000 and -1200 (IL10R and IL10G, respectively) and single nucleotide polymorphisms (SNPs) (MS) at positions -1082G/A, -819C/T and -592C/A of the IL-10 promoter were analysed in patients with SLE and healthy controls from Canary Islands (Spain). We found that SNPs but not MS were associated with SLE. The GCC haplotype frequency was significantly higher in SLE patients (0.43) than in healthy donors (0.33) [P = 0.02; OR = 1.50 (95% CI = 1.06-2.14)], whereas the ACC haplotype was less represented in patients (0.28 vs. 0.37) [P = 0.02; OR = 0.64 (95% CI = 0.44-0.92)]. To assess the functional role of genotypes, serum IL-10 levels from patients and controls were quantified by ELISA. Also, the lipopolysaccharide-induced IL-10 secretion by monocytes from healthy controls was evaluated in vitro. Serum IL-10 levels were higher in patients [median (interquartile range) = 2.8 pg/mL (1.8-4.2)] than in controls [0.9 pg/mL (0-3.5)] (P = 0.02), but no association was observed between serum IL-10 levels or lipopolysaccharide-induced IL-10 secretion and the IL-10 promoter haplotypes. These data suggest that the IL-10 promoter haplotype that produces higher levels of cytokine is associated with SLE in patients from Canary Islands.
ISSN: 1744-3121
DOI: 10.1111/j.1744-313X.2008.00762.x
Source: International Journal Of Immunogenetics[ISSN 1744-3121],v. 35 (3), p. 235-242
Appears in Collections:Artículos
Show full item record


checked on Aug 14, 2022


checked on Aug 14, 2022

Page view(s)

checked on Jun 12, 2022

Google ScholarTM




Export metadata

Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.